RESOURCES FOR PHARMACISTS AND OTHER HEALTHCARE PROFESSIONALS
The Connecticut Pharmacists Association has compiled recommendations from the CDC, FDA, other states, national associations, and other sources to help pharmacists and their staff members practice in a safe and effective manner.
VIDEO HOMESTUDY: Pharmacist-Directed COVID-19 Testing Training Program
Authorization for Connecticut Pharmacists to Order and Administer COVID-19 Tests (May 7 2020)
CLIA Waiver: Application for Certification (download the form here)
CTDPH COVID-19 EUA Quality and Safety Survey (download the form here)
Connecticut DCP “Pharmacist Role in COVID-19 Testing FAQ” (May 8, 2020)
CDC: “Ready! Set! TEST!: Patient Testing is Important–Get the Right Results”
Frequently Asked Questions: Laboratory Data Reporting for COVID-19 Testing
Abbott ID Now COVID-19 Test System Materials
- Connecticut
- State of Connecticut Coronavirus Homepage
- Frequently Asked Questions on the State of Connecticut’s Actions Related to COVID-19
- “Essential Businesses” order
- Guidance re: pharmacy hours, pharmacist/technician ratios, and newly-designated pharmacy managers
- Garbing Guidance
- Remote Data Entry and Remote Data Entry Verification Guidance
- Hand Sanitizer Compounding Guidance
- Implementation Order Permitting Pharmacies to Compound and Sell Hand Sanitizer
- Suspension of Garbing Requirements For Non-Hazardous Compounding of Sterile Pharmaceuticals
- Flexibility to Provide For Adequate Healthcare Resources and Facilities
- Expansion of Medicaid Telehealth Coverage to Audio-Only Telephone
- Restrictions on Workplaces for Non-Essential Businesses
- Suspension of limitations on refills of non-maintenance medications for HUSKY beneficiaries
- Pharmacist Discretion in Refilling Certain Prescriptions for Longer Periods
- Commissioner Authority to Modify Pharmacy Operation Regulations
- Suspension or Modification of Regulatory Requirements to Protect Public Health and Safety
- Flexibility to Maintain Adequate Medical Marijuana Access for Patients
- Order allowing out-of-state practitioners (including pharmacy) to render temporary assistance in Connecticut
- Centers for Disease Control and Prevention (CDC)
- Coronavirus Main Page
- Situation Summary
- Preparedness Checklist
- Guidance for Community Pharmacies
- Interim Guidance for Immunization Services During the COVID-19 Pandemic
- Infection Prevention and Control Recommendations
- Therapeutic Options for Patients with COVID-19
- Cases in the U.S.
- Risk Assessment
- Information for Health Care Personnel
- Information for Laboratories
- Strategies for Optimizing the Supply of PPE
- Recommendations for Health Care Professionals with Potential Exposure in a Healthcare
- Clinical Questions About COVID-19: Q&A
- Centers for Medicare and Medicaid Services (CMS)
- Coronavirus Main Page
- Minimizing Face-to-Face Contact for Medication Delivery or Dispensing
- Suspension of Non-Emergency Inspections Across the Country
- Infection Control Guidance for Health Care Facilities
- Infection Control Guidance for Hospitals
- Infection Control Guidance for Long-Term Care Facilities
- Infection Control Guidance for Hospice Agencies
- Infection Control Guidance for Home Health Agencies
- Infection Control Guidance for Dialysis Facilities
- New Lab Testing Codes for Coronavirus
- Guidance to Medicare Advantage and Part D Plans Regarding Prescription Drugs
- Food and Drug Administration (FDA)
- Coronavirus Main Page
- Guidance Regarding Pharmacists and Ordering/Administering COVID-19 Tests
- Guidance on Development & Licensure of COVID-19 Vaccines
- Updated Guidance on Manufacturing & Compounding of Certain Alcohol-Based Hand Sanitizer Products
- Policy for Temporary Compounding of Certain Alcohol-Based Hand Sanitizer Products
- Q&A for Consumers: Hand Sanitizers & COVID-19
- Temporary Policy on Prescription Drug Marketing Act Requirements for Distribution of Drug Samples During the COVID-19 Public Health Emergency
- Policy for Certain REMS Requirements During the COVID-19 Public Health Emergency
- US Department of Labor
- Occupational Safety and Health Administration (OSHA)
- World Health Organization (WHO)
- Drug Enforcement Administration (DEA)
- US Pharmacopeia (USP)
- Infectious Diseases Society of America (IDSA)
- APhA CE Series: “15 on COVID-19”
- Recent Episodes
- Calls/Webinars presented by CDC for Clinician Outreach and Communication Activity (COCA)
- Recent Calls/Webinars
- Podcast Series presented by IDSA on COVID-19: What’s Happening Now
- Recent Soundcloud Podcasts
- Johns Hopkins Coronavirus Resource Center
- Clinical Information
- Personal Protective Equipment (PPE) Information
- Pharmacy Benefits Manager (PBM) Changes
- National Pharmacy Organizations’ COVID-19 Information Pages
***Disclaimer: The web page may contain links to other websites or content belonging to or originating from third-parties or links to websites and features and banners or other advertising. Such external links are not investigated or monitored or checked for accuracy, adequacy, validity, reliability, availability or completeness by us. Connecticut Pharmacy Association does not warrant, endorse, guarantee, or assume responsibility for the accuracy or the reliability of any information offered by third-party websites linked through the site or any other website or feature linked in any banner or other advertising.